1. Angiotensin receptor blockers and COVID-19;Saavedra;Pharmacol. Res.,2020
2. Y. Huang, C.M. Xie, X. Chen, Q. Hong, H. Huang Would ACEI/ARBs be beneficial for COVID-19 patients without hypertension? Pharmacological Research, YPHRS-S-20-0119, in press.
3. COVID-19, angiotensin receptor blockers, and the brain;Saavedra;Cell. Mol. Neurobiol.,2020
4. Effects of ARBs and ACEIs on virus infection, inflammatory status and clinical outcomes in COVID-19 patients with hypertension: a single center retrospective study;Yang;Hypertension,2020
5. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study;de Abajo;Lancet,2020